Hydrochloric Acid → N-(4-(((3S,5S)-3,5-Dimethylmorpholino)methyl)-2,5-difluorophenyl)-5-fluoro-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine hydrochloride
反応式
[CH3:1][C@@H:2]1[N:7]([CH2:8][C:9]2[C:14]([F:15])=[CH:13][C:12]([NH:16][C:17]3[N:22]=[C:21]([C:23]4[N:27]([CH:28]5[CH2:33][CH2:32][O:31][CH2:30][CH2:29]5)[C:26]([CH3:34])=[N:25][CH:24]=4)[C:20]([F:35])=[CH:19][N:18]=3)=[C:11]([F:36])[CH:10]=2)[C@@H:6]([CH3:37])[CH2:5][O:4][CH2:3]1.[ClH:38]>ClCCl>[ClH:38].[CH3:1][C@@H:2]1[N:7]([CH2:8][C:9]2[C:14]([F:15])=[CH:13][C:12]([NH:16][C:17]3[N:22]=[C:21]([C:23]4[N:27]([CH:28]5[CH2:33][CH2:32][O:31][CH2:30][CH2:29]5)[C:26]([CH3:34])=[N:25][CH:24]=4)[C:20]([F:35])=[CH:19][N:18]=3)=[C:11]([F:36])[CH:10]=2)[C@@H:6]([CH3:37])[CH2:5][O:4][CH2:3]1参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
N-(4-(((3S,5S)-3,5-dimethylmorpholino)methyl)-2,5-difluorophenyl)-5-fluoro-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine (16 mg) was dissolved in dichloromethane (4 ml) and HCl (1M in diethyl ether, 0.05 ml) was added. The solvents were evaporated to give the title compound (0.015 g) as a solid.
後処理
- customThe solvents were evaporated
出典と根拠
- ORDレコード
- ord-41addefe23d442708ddf864b4c61529d
- 出典データセット
- uspto-grants-2012_05
- 特許番号
- US08178529B2
反応ノート
読み込み中…